caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1245239094

Mark YantaM.D.

OtolaryngologyAlpharetta, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 110005
Hospital
CCN 110161
Hospital
REFERRAL NETWORK

Where Mark Yanta's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAMAH, THERESA5780
NORTHSIDE HOSPITAL, INC.4770
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
3762
SOLSTAS LAB PARTNERS GROUP LLC1753
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NORTHSIDE HOSPITAL, INC.54118
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
46100
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Tucker, GA
4586
WELLSTAR NORTH FULTON HOSPITAL, INC1940
SOLSTAS LAB PARTNERS GROUP LLC1228
OPEN MRI OF GEORGIA, INC1114
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
586
Unique beneficiaries
—
Total services
685
Distinct HCPCS
9
Medicare payment
$44K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 300 Otolaryngology providers in GA — below median (cohort median 955).
PRESCRIBING · PART D · 2024
Total Rx claims
782
Beneficiaries
—
Total drug cost
$75K
Distinct drugs
11
Brand share
11.4%
Top prescribed drugs
Azelastine Hcl323 claims
Fluticasone Propionate164 claims
Ipratropium Bromide143 claims
Doxycycline Hyclate25 claims
Mupirocin24 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$933
Payment records
28
By payment type
Food and Beverage$876
Education$58